Literature DB >> 36229885

Clinical characteristics of sitosterolemic children with xanthomas as the first manifestation.

Jun Zhang1, Qiu-Li Chen1, Song Guo1, Yan-Hong Li1, Chuan Li2, Ru-Jiang Zheng1, Xue-Qun Luo3, Hua-Mei Ma4.   

Abstract

BACKGROUND: Sitosterolemia (STSL) is an extremely rare genetic disease. Xanthomas as the first symptom are frequently misinterpreted as familial hypercholesterolemia (FH) in children. Inappropriate treatment may deteriorate the condition of STSL.
OBJECTIVES: To present the clinical and laboratory characteristics of xanthomatous children diagnosed with sitosterolemia in comparison with childhood FH with xanthomas.
METHODS: We summarized and compared the clinical characteristics of STSL and FH patients with xanthomas as the first manifestations and investigated the different indicators between the STSL and FH groups, as well as their diagnostic values for STSL.
RESULTS: Two tertiary pediatric endocrinology departments contributed ten STSL cases. Five of the STSL patients (50%) experienced mild anemia, whereas two (20%) had vascular complications. The xanthomas of the STSL group displayed morphologies comparable to those of the FH group. There were ten cases of homozygous FH (HoFH) with xanthomas as the predominant symptom of the control group who had no anemia. The serum cholesterol (Chol) levels of the STSL and FH groups were 12.57 (9.55 ~ 14.62) mmol/L and 17.45 (16.04 ~ 21.47) mmol/L, respectively (p value 0.002). The serum low-density lipoprotein cholesterol (LDL-c) levels of the STSL and FH groups were 9.26 ± 2.71 mmol/L and 14.58 ± 4.08 mmol/L, respectively (p value 0.003). Meanwhile, the mean platelet volume (MPV) levels of the STSL and FH groups were 11.00 (9.79 ~ 12.53) fl. and 8.95 (8.88 ~ 12.28) fl., respectively (p value 0.009). The anemia proportions of the STSL and FH groups were 50% and 0%, respectively (p value 0.033). The AUC values of Chol, LDL-c, MPV, hemoglobin (Hb) for the diagnosis of STSL were 0.910, 0.886, 0.869, 0.879, respectively. Chol ≤ 15.41 mmol/L, LDL-c ≤ 13.22 mmol/L, MPV ≥ 9.05 fl., or Hb≤120 g/L were the best thresholds for diagnosing STSL with childhood xanthomas.
CONCLUSION: The xanthoma morphology of STSL patients resembles that of FH patients. Xanthomas as the initial symptom of a child with Chol ≤ 15.41 mmol/L, LDL-c≤13.22 mmol/L, MPV ≥ 9.05 fl., or Hb≤120 g/L, he was most likely to have STSL.
© 2022. The Author(s).

Entities:  

Keywords:  Anemia; Familial hypercholesterolemia; Mean platelet volume; Plant sterols; Sitosterolemia; Xanthoma

Mesh:

Substances:

Year:  2022        PMID: 36229885      PMCID: PMC9563796          DOI: 10.1186/s12944-022-01710-1

Source DB:  PubMed          Journal:  Lipids Health Dis        ISSN: 1476-511X            Impact factor:   4.315


  36 in total

Review 1.  The Agenda for Familial Hypercholesterolemia: A Scientific Statement From the American Heart Association.

Authors:  Samuel S Gidding; Mary Ann Champagne; Sarah D de Ferranti; Joep Defesche; Matthew K Ito; Joshua W Knowles; Brian McCrindle; Frederick Raal; Daniel Rader; Raul D Santos; Maria Lopes-Virella; Gerald F Watts; Anthony S Wierzbicki
Journal:  Circulation       Date:  2015-10-28       Impact factor: 29.690

2.  Sitosterolaemia: a rare cause of accelerated atherosclerosis.

Authors:  Tim M Reynolds
Journal:  J Clin Pathol       Date:  2018-10       Impact factor: 3.411

Review 3.  Recent advances in Phytosterol Oxidation Products.

Authors:  Yvonne O'Callaghan; Florence O McCarthy; Nora M O'Brien
Journal:  Biochem Biophys Res Commun       Date:  2014-01-31       Impact factor: 3.575

4.  Sitosterol-containing lipoproteins trigger free sterol-induced caspase-independent death in ACAT-competent macrophages.

Authors:  Liping Bao; Yankun Li; Shi-Xian Deng; Donald Landry; Ira Tabas
Journal:  J Biol Chem       Date:  2006-08-24       Impact factor: 5.157

5.  A case of ezetimibe-effective hypercholesterolemia with a novel heterozygous variant in ABCG5.

Authors:  Yujiro Nakano; Chikara Komiya; Hitomi Shimizu; Hiroyuki Mishima; Kumiko Shiba; Kazutaka Tsujimoto; Kenji Ikeda; Kenichi Kashimada; Sumito Dateki; Koh-Ichiro Yoshiura; Yoshihiro Ogawa; Tetsuya Yamada
Journal:  Endocr J       Date:  2020-07-09       Impact factor: 2.349

6.  Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption.

Authors:  M H Lee; K Lu; S Hazard; H Yu; S Shulenin; H Hidaka; H Kojima; R Allikmets; N Sakuma; R Pegoraro; A K Srivastava; G Salen; M Dean; S B Patel
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

7.  Stomatocytic haemolysis and macrothrombocytopenia (Mediterranean stomatocytosis/macrothrombocytopenia) is the haematological presentation of phytosterolaemia.

Authors:  David C Rees; Achille Iolascon; Massimo Carella; Aengus S O'marcaigh; James R Kendra; Simon N Jowitt; J K Wales; Ajay Vora; M Makris; Nigel Manning; Anna Nicolaou; Julie Fisher; Anuska Mann; Samuel J Machin; Peter T Clayton; Paolo Gasparini; Gordon W Stewart
Journal:  Br J Haematol       Date:  2005-07       Impact factor: 6.998

8.  ABCG5 and ABCG8 gene variations associated with sitosterolemia and platelet dysfunction.

Authors:  Jose María Bastida; Rocío Benito; José Ramón González-Porras; José Rivera
Journal:  Platelets       Date:  2020-06-16       Impact factor: 3.862

9.  A case of sitosterolemia due to compound heterozygous mutations in ABCG5: clinical features and treatment outcomes obtained with colestimide and ezetimibe.

Authors:  Sahoko Ono; Junko Matsuda; Aki Saito; Takenobu Yamamoto; Wataru Fujimoto; Hitomi Shimizu; Sumito Dateki; Kazunobu Ouchi
Journal:  Clin Pediatr Endocrinol       Date:  2017-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.